跳至主要内容
临床试验/TCTR20200526010
TCTR20200526010已完成2 期

Clinical efficacy of polycaprolactone membrane for bone augmentation in dental implant treatment: Pilot study

Faculty of Dentistry, Thammasat University0 个研究点目标入组 24 人开始时间: 2020年5月26日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
24

研究概览

简要总结

The augmented alveolar ridge was evidently successful in both groups while slightly resorbed at 6-months follow-up. Minimal loss of STC was observed in both groups up to 1 year of loading. No statistically significant difference was found between the two groups in all assessed outcomes.

研究设计

研究类型
Interventional

入排标准

年龄范围
20 Years 至 70 Years(—)
性别
Male

入选标准

  • 1.Adult patients (age 20-70 years)
  • 2.Good general health (ASA 1, 2) and not a contraindication for minor surgery
  • 3.The diagnosis and indications for a particulate bone substitute include:
  • a.Alveolar bone defects, class 2 (Benic & Hammerle 2014).
  • b.The edentulous area allows placement of at least one standard implant and not exceed a two-tooth span.
  • 4.Patients who needed reconstruction of the edentulous sites with simultaneous implant placement
  • 5.Controlled periodontitis.
  • 6.Smoking history <10 cigarettes per day. For the subject who smokes but less than 10 cigarettes per day is requested to stop smoking two weeks before and after bone block graft surgery and implant placement
  • 7.No history of allergy or hypersensitivity to any materials to be used in the study.
  • 8.Signed informed consent.

排除标准

  • 1.Presence of relevant medical conditions: Patients with bone disease, osteoporosis, uncontrolled diabetes mellitus, unstable or life-threatening conditions, or requiring antibiotic prophylaxis. Patients with medication of drugs influencing the bone metabolism or use of bisphosphonates.
  • 2.Pregnancy or lactation.
  • 3.Patients who have poor oral hygiene.
  • 4.Patients with active infection or pathologic lesions prior to operation
  • 5.Patients who cannot take impression (both conventional and digital) and CBCT
  • 6.History of malignancy, radiotherapy, or chemotherapy for malignancy in the past 5 years.
  • 7.History of autoimmune disease or long-term prescribed of nonsteroidal anti-inflammatory drugs
  • 8.Unwillingness to return for the follow-up examination.

研究者

发起方
Faculty of Dentistry, Thammasat University

相似试验